// App-Quantinova.ai

: Evaluation of the Clinical Utility of Biomarkers for Stroke Risk Scoring in Non‐anticoagulated Patients with Atrial Fibrillation – An ACTIVE‐A and AVERROES Sub‐analysis

Researchers

Presenter

  • M. Lauw

Principal Investigators

  • T. Vanassche

  • J. Wang

  • R. Hart

  • J. Eikelboom

  • S. Connolly

Medical Centers

  • Population Health Rsch Institute, McMaster Univ, Hamilton, Canada

  • Amsterdam Cardiovascular Sciences, Amsterdam UMC, location AMC, Dept. of Vascular Medicine, Amsterdam, the Netherlands

  • KU Leuven, Center for Molecular and Vascular Biology, Department of Cardiovascular Sciences, Leuven, Belgium

  • Thrombosis and Atherosclerosis Research Institute, Dept. of Medicine, Hamilton, Canada

Locations

  • Canada

  • Netherlands

  • Belgium

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

  • Cardiovascular (CVS)

Disease

  • Arrhythmia

  • Stroke

Biomarkers

  • N/A

Drug/Treatment

  • apixaban

  • Aspirin

  • Albyl-E

Outcome

  • N/A

Study Design

  • Randomized

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved